Ph-negative MPN
Hu Z, Medeiros LJ, Wang W, Chen Z, Tang G, Hodjat P, Yang S, Fang L, Li Y, Verstovsek S, Hu S. 3q26.2 rearrangement is associated with poor prognosis in Ph-negative myeloproliferative neoplasm. Mod Pathol. 2017 Jul;30(7):940-951. doi: 10.1038/modpathol.2017.19. PMID: 28338652
Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica. 2017 Sep:102(9):1511-1518. doi: 10.3324/haematol.2017.165795. PMID: 28473622
Loghavi S, Sui D, Wei P, Garcia-Manero G, Pierce S, Routbort MJ, Jabbour EJ, Pemmaraju N, Kanagal-Shamanna R, Gur HD, Hu S, Zuo Z, Medeiros LJ, Kantarjian HM, Khoury JD. Validation of WHO 2017 Chronic myelomonocytic leukemia categories. Blood Adv. 2018 Aug 14;2(15):1807-1816. doi: 10.1182/bloodadvances.2018019224.
Tang G, Zhang L, Fu B, Hu J, Lu X, Hu S, Patel A, Goswami M, Khoury JD, Garcia-Manero G, Medeiros LJ, Wang SA. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institute. Am J Hematol. 2014 Aug;89(8):813-8. doi: 10.1002/ajh.23751. PMID: 24782398
Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang SA. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. Am J Hematol. 2015 Oct;90(10):882-7. doi: 10.1002/ajh.24108. PMID: 26148174
Tashakori M, Khoury JD, Routbort MJ, Patel KP, Wang SA, Ok CY, El Hussein S, Kanagal-Shamanna R, Luthra R, Hu S, Lin P, Pemmaraju N, Bose P, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Mod Pathol. 2022 Nov;35(11):1677-1683. doi: 10.1038/s41379-022-01118-3. PMID: 35690645.
Hu Z, Hu S, Ji C, Tang Z, Thakral B, Loghavi S, Medeiros LJ, Wang W. 3q26.2/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: an early event associated with a poor prognosis. Leuk Res. 2018 Feb;65:25-28. doi: 10.1016/j.leukres.2017.12.004. PMID: 29288910
Hidalgo-Lopez JE, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol. 2018 Mar;97(3):425-434. doi: 10.1007/s00277-017-3211-7. PMID: 29285580
Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Verstovsek S, Lin P. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic leukemia from primary myelofibrosis with monocytosis. Hum Pathol. 2019 Mar;85:290-298. doi: 10.1016/j.humpath.2018.10.026. doi: 10.1016/j.humpath.2018.10.026. PMID: 30447300
Xie W, Wang SA, Hu S, Xu J, Medeiros LJ, Tang G. Myeloproliferative neoplasm with ABL1/EVT6 rearrangement mimics chronic myeloid leukemia and responses to tyrosine kinase inhibitors. Cancer Genet. 2018 Dec;228-229:41-46. doi: 10.1016/j.cancergen.2018.08.002. PMID: 30553471
Xie W, Chen Z, Wang SA, Hu S, Li S, Miranda RN, Medeiros LJ, Tang G. Lymphocytic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Leuk Lymphoma. 2019 Apr 24:1-9. doi: 10.1080/10428194.2019.1605509. PMID: 31017498
Chen Z, Wang W, Verstovsek S, Cortes JE, Medeiros LJ, Hu S. Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm. Int J Lab Hematol. 2015 Jun 18. doi: 10.1111/ijlh.12398. PMID: 26086872
Gong Z, Hu S. Recent advances in diagnosis and management of chronic neutrophilic leukemia. Chin J Practical Internal Med 2018 Feb 38(2):123-126
Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):629-33. doi: 10.1016/j.clml.2012.12.013. PMID: 23800601
Manola, A, Kourelis TV, Busman B, Hu S, Marks P, Thompson PD. Mastocytosis causing refractory hypotension after coronary angiography. Int J Cardiol. 2012 Apr 19;156(2):e43-4. doi: 10.1016/j.ijcard.2011.08.017. PMID: 21917341
Tang G, Hidalgo Lopez JE, Wang SA, Hu S, Ma J, Pierce S, Zuo W, Carballo-Zarate AA, Yin CC, Tang Z, Li S, Medeiros LJ, Verstovsek S, Bueso-Ramos CE. Characteristics and clinical significance of cytogenetic abnormalities in polycythemia vera. Haematologica. 2017 Sep:102(9):1511-1518. doi: 10.3324/haematol.2017.165795. PMID: 28473622
Loghavi S, Sui D, Wei P, Garcia-Manero G, Pierce S, Routbort MJ, Jabbour EJ, Pemmaraju N, Kanagal-Shamanna R, Gur HD, Hu S, Zuo Z, Medeiros LJ, Kantarjian HM, Khoury JD. Validation of WHO 2017 Chronic myelomonocytic leukemia categories. Blood Adv. 2018 Aug 14;2(15):1807-1816. doi: 10.1182/bloodadvances.2018019224.
Tang G, Zhang L, Fu B, Hu J, Lu X, Hu S, Patel A, Goswami M, Khoury JD, Garcia-Manero G, Medeiros LJ, Wang SA. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institute. Am J Hematol. 2014 Aug;89(8):813-8. doi: 10.1002/ajh.23751. PMID: 24782398
Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang SA. Prognostic impact of acquisition of cytogenetic abnormalities during the course of chronic myelomonocytic leukemia. Am J Hematol. 2015 Oct;90(10):882-7. doi: 10.1002/ajh.24108. PMID: 26148174
Tashakori M, Khoury JD, Routbort MJ, Patel KP, Wang SA, Ok CY, El Hussein S, Kanagal-Shamanna R, Luthra R, Hu S, Lin P, Pemmaraju N, Bose P, Verstovsek S, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Clinicopathologic spectrum of myeloid neoplasms with concurrent myeloproliferative neoplasm driver mutations and SRSF2 mutations. Mod Pathol. 2022 Nov;35(11):1677-1683. doi: 10.1038/s41379-022-01118-3. PMID: 35690645.
Hu Z, Hu S, Ji C, Tang Z, Thakral B, Loghavi S, Medeiros LJ, Wang W. 3q26.2/EVI1 rearrangement in myelodysplastic/myeloproliferative neoplasms: an early event associated with a poor prognosis. Leuk Res. 2018 Feb;65:25-28. doi: 10.1016/j.leukres.2017.12.004. PMID: 29288910
Hidalgo-Lopez JE, Verstovsek S, Wang SA, Hu S, Li S, Xu J, Tang Z, Yin CC, Medeiros LJ, Bueso-Ramos CE, Tang G. Bone marrow findings in blast phase of polycythemia vera. Ann Hematol. 2018 Mar;97(3):425-434. doi: 10.1007/s00277-017-3211-7. PMID: 29285580
Hu Z, Ramos CEB, Medeiros LJ, Zhao C, Yin CC, Li S, Hu S, Wang W, Thakral B, Verstovsek S, Lin P. Utility of JAK2 V617F allelic burden in distinguishing chronic myelomonocytic leukemia from primary myelofibrosis with monocytosis. Hum Pathol. 2019 Mar;85:290-298. doi: 10.1016/j.humpath.2018.10.026. doi: 10.1016/j.humpath.2018.10.026. PMID: 30447300
Xie W, Wang SA, Hu S, Xu J, Medeiros LJ, Tang G. Myeloproliferative neoplasm with ABL1/EVT6 rearrangement mimics chronic myeloid leukemia and responses to tyrosine kinase inhibitors. Cancer Genet. 2018 Dec;228-229:41-46. doi: 10.1016/j.cancergen.2018.08.002. PMID: 30553471
Xie W, Chen Z, Wang SA, Hu S, Li S, Miranda RN, Medeiros LJ, Tang G. Lymphocytic leukemia following myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms. Leuk Lymphoma. 2019 Apr 24:1-9. doi: 10.1080/10428194.2019.1605509. PMID: 31017498
Chen Z, Wang W, Verstovsek S, Cortes JE, Medeiros LJ, Hu S. Chronic myelogenous leukemia in patients with MPL or JAK2 mutation-positive myeloproliferative neoplasm. Int J Lab Hematol. 2015 Jun 18. doi: 10.1111/ijlh.12398. PMID: 26086872
Gong Z, Hu S. Recent advances in diagnosis and management of chronic neutrophilic leukemia. Chin J Practical Internal Med 2018 Feb 38(2):123-126
Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P. Metastatic splenic angiosarcoma presenting with thrombocytopenia and bone marrow fibrosis mimicking idiopathic thrombocytopenic purpura and primary myelofibrosis: a diagnostic challenge. Clin Lymphoma Myeloma Leuk. 2013 Oct;13(5):629-33. doi: 10.1016/j.clml.2012.12.013. PMID: 23800601
Manola, A, Kourelis TV, Busman B, Hu S, Marks P, Thompson PD. Mastocytosis causing refractory hypotension after coronary angiography. Int J Cardiol. 2012 Apr 19;156(2):e43-4. doi: 10.1016/j.ijcard.2011.08.017. PMID: 21917341